… and anti-inflammatory drugs. However, traditional anti-oxidant pharmacological therapies
are … such as low diffusion rate and inappropriate drug pharmacokinetics. Recent advances in …

… Chronic obstructive pulmonary disease (COPD) is one of the major diseases threatening
human life and health. According to the report released by the World Health Organization (WHO…

Rationale: Azithromycin prevents acute exacerbations of chronic obstructive pulmonary disease
(AECOPDs); however, its value in the treatment of an AECOPD requiring hospitalization …

… about administration of flavonoids from TCM for treating COPD from January 2010 to … :
chronic obstructive pulmonary disease or chronic respiratory disease or inflammatory lung disease…

… first-line therapy to address disease symptoms and to prevent exacerbations in patients with
chronic obstructive pulmonary disease (… that medication immediately prior to the study drug. …

… Chronic obstructive pulmonary disease (COPD) is emphysema and/or chronic bronchitis
characterised by long-term … last decade and the drugs most commonly used to treat it, such as …

… Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

Disclosures: Dr. Labaki, ACP Contributing Author, reports nonfinancial support from Pulmonx
and personal fees from Konica Minolta outside the submitted work. Dr. Rosenberg, ACP …

… of chronic obstructive pulmonary disease (COPD) are associated with a significant
mortality, health and economic burden. Their diagnosis, assessment and management remain …

… 12% and 3 million deaths annually, chronic obstructive pulmonary disease (COPD) is a major
… The initial pharmacological treatment and escalation of therapy algorithm is presented in …